Biotech companies in the United States by P/S ratio

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Biogen has the lowest figure of the 15 biotech companies in the United States ranked by P/S ratio, at 3.7, followed by Neurocrine Biosciences (5.4) and Amgen (6.5). Figures as of 20 Nov 2026, 18:18 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
15
Lowest
Biogen3.7
Median
14.3
Combined market value
SGD 947.2B
Countries
1
Not ranked
5no P/S ratio on file

Market values as of .

United States
All sectors
Biotech
SGD
Clear filters
Biotech companies in the United States by P/S ratio
#CompanyP/S ↑Market capPriceToday1 yearPrice, 30 daysCountry
1BiogenBIIB · Health Care3.7SGD 47.7BSGD 322.82 1.27% up 41% up United States
2Neurocrine BiosciencesNBIX · Health Care5.4SGD 20.1BSGD 198.14 1.91% down 10% up United States
3AmgenAMGN · Health Care6.5SGD 306.5BSGD 566.68 0.69% up 30% up United States
4ExelixisEXEL · Health Care6.9SGD 20.7BSGD 84.68 0.28% down 55% up United States
5Gilead SciencesGILD · Health Care7.1SGD 269.9BSGD 217.58 1.29% up 31% up United States
6Halozyme TherapeuticsHALO · Health Care7.6SGD 13.7BSGD 119.88 0.11% down 32% up United States
7Bio-TechneTECH · Health Care9.4SGD 14.7BSGD 93.81 0.03% up 18% up United States
8RepligenRGEN · Health Care14.3SGD 13.7BSGD 213.55 2.78% down 5% up United States
9Adaptive BiotechnologiesADPT · Health Care16.3SGD 5.8BSGD 35.92 0.73% down 51% up United States
10Twist BioscienceTWST · Health Care19.1SGD 9.3BSGD 136.12 5.46% down 291% up United States
11Krystal BiotechKRYS · Health Care24.0SGD 12BSGD 406.61 0.19% down 49% up United States
12ModernaMRNA · Health Care40.5SGD 101.6BSGD 251.09 2.35% down 740% up United States
13ImmunityBioIBRX · Health Care57.0SGD 8.3BSGD 7.83 7.64% down 216% up United States
14Kymera TherapeuticsKYMR · Health Care250SGD 12.7BSGD 148.29 3.71% down 81% up United States
15CG OncologyCGON · Health Care1786SGD 9.3BSGD 104.22 1.36% down 93% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2899 SGD). 5 companies have no P/S ratio on file and are not ranked here.

Questions and answers

Which biotech companies in the United States have the lowest P/S ratio?

Biogen (3.7), Neurocrine Biosciences (5.4) and Amgen (6.5) have the lowest P/S ratio of the 15 biotech companies in the United States ranked here as of 20 Nov 2026, 18:18 UTC.

How many biotech companies in the United States are in this ranking?

15 are ranked by P/S ratio. 5 more have no P/S ratio on file and are left out rather than ranked at zero.

What are these biotech companies in the United States worth together?

The 15 biotech companies in the United States ranked by P/S ratio have a combined market value of SGD 947.2B as of 20 Nov 2026, 18:18 UTC.

What does ranking by P/S ratio measure?

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Cite this page

Funkfolio, “Biotech companies in the United States by P/S ratio”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=ps-ratio

Underlying data: Yahoo Finance; SEC EDGAR.